Its predictive and prognostic value in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant chemotherapy
Received: 11 August 2015 / Accepted: 20 October 2015 / Published online: 26 October 2015 Springer Science+Business Media New York 2015